Persistent Phenotypic Responses of Human Mammary Epithelial Cells Induced by Ionizing Radiation by Andarawewa L Kumari et al.
Introduction
An emerging concept in cancer biology is that carcinogens can
compromise tissue integrity by eliciting altered phenotypes and tis-
sue composition (reviewed in ref. 1). Intercellular and extracellular
signals are critical to the suppression of neoplastic growth, whereas
disruption of cell-cell and cell-matrix interactions is implicated, if not
required, for neoplastic progression. Indeed, reversion of the malig-
nant phenotype by modulating extracellular signals suggests that can-
cer cells are susceptible to signals from the microenvironment.2
It has been shown that ionizing radiation (IR) activates multiple
signaling pathways depending on the cell type, radiation dose, and
cell status (reviewed in ref. 3). We have previously shown that trans-
forming growth factor ß1 (TGFß) is activated following IR, and that
it, in turn, mediates cellular and tissue radiation responses.4,5 Although
TGFß is considered to be a potent tumor suppressor during the ini-
tial stage of tumorigenesis, numerous reports show that TGFß can
switch to tumor promoter during neoplastic progression (reviewed
in ref. 6). Some epithelial tumors, particularly those that overexpress
TGFß, exhibit mesenchymal characteristics and are more aggressive.7
Several lines of evidence have led researchers to link this morphol-
ogic shift during carcinogenesis to the physiologic process of epithe-
lial to mesenchymal transition (EMT). We have postulated that IR
alters cell phenotypes, which in turn contribute, directly or indirectly,
to carcinogenesis.8 Thus we examined the persistent radiation-induced
phenotypes in non-malignant HMEC that affect pathways that precede
neoplasia.
Materials and Methods
Human mammary epithelial cells (HMEC) were cultured in se-
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Ionizing radiation (IR) is a known human breast carcinogen. Although the mutagenic capacity of IR is widely acknowledged as the basis for
its action as a carcinogen, we and others have shown that IR can also induce growth factors and extracellular matrix remodeling. We have
shown that irradiating human mammary epithelial cells (HMEC) cultured with transforming growth factor ß1 (TGFß) can generate a persistent
phenotype in daughter cells characterized by spindle cell morphology, increased mesenchymal markers, decreased epithelial markers and in-
creased cellular motility and invasion, which are hallmarks of epithelial to mesenchymal transition (EMT). Neither radiation nor TGFß alone elic-
ited EMT, although IR increased chronic TGFß signaling and activity. Gene expression profiling revealed that double-treated cells exhibit a spe-
cific 10-gene signature associated with Erk/MAPK signaling. We hypothesized that IR-induced MAPK activation primes nonmalignant HMEC
to undergo TGFß-mediated EMT. Consistent with this, Erk phosphorylation was transiently induced by irradiation and persisted in irradiated
cells treated with TGFß, and inhibition of Erk activation, blocked the EMT phenotype. Preliminary studies suggest that eqi-toxic doses of
sparsely and densely ionizing radiation resulted in comparable EMT when cells were cultivated in the presence of TGFß. Furthermore radiation
dose response studies show that this effect has a very low threshold in that a single exposure of 3-200 cGy radiation elicits the 'same' pheno-
typic switch, which is consistent with non-targeted effects. Together, these data show that the interactions between radiation-induced signaling
pathways elicit heritable phenotypes that could contribute to radiation carcinogenesis.
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rum-free medium as previously described for HMT-3522 S1 (S1;
passages 55–60), MCF10A (ATCC, Manassas,VA ), 184 HMEC
(184v; passage 7–10) and HMT-3522-S2 (S2).9 Recombinant human
TGFß (400 pg/ml) was added at the time of plating or of irradia-
tion. HMEC were irradiated 4-5h (S1, MCF10A and S2) or 10-14h
(184v HMEC) post plating. Three dimensional (3D) cultures were
done as previously described.10 Radiation treatments were performed
with either 160 kV X-ray or 60Co ã-radiation with a total dose of 2
Gy. Some cells were irradiated with a 5600 curie source of 137Cs for
ã-radiation over a dose range of 0-2Gy or with 1 GeV/amu 56Fe ions
from the NASA Space Radiation Laboratory of the Brookhaven
National Laboratory. Microarray analysis, migration and invasion
assays were done as described previously.9
Results
The progeny of irradiated nonmalignant HMEC cultured with TGFß
(double-treated: IR + TGFß)] exhibit compromised morphogenesis,
polarity, and growth control when cultured in Matrigel.10 To examine
the possibility that EMT underlies the response to radiation and
TGFß, we compared the epithelial characteristics of HMEC in tradi-
tional monolayer culture. Epithelial markers, E-cadherin, ß-catenin,
and ZO-1 were reduced in double-treated cells, while mesenchymal
markers, N-cadherin, fibronectin, and vimentin were dramatically in-
creased. Double-treated cells also underwent disrupted morphogenesis
when propagated in Matrigel in the absence of additional TGFß.
The functional consequence of the response of irradiated HMEC to
TGFß was analyzed by the migratory and invasive properties of dou-
ble-treated HMEC. TGFß induced an increase in motility and inva-
siveness in irradiated HMEC. Although IR induced TGFß activity in
cultured HMEC as it did in the mouse mammary gland, it was insuf-
ficient to disrupt HMEC acinar morphogenesis as shown in our pre-
vious study.4,10 Thus, chronic TGFß activation by irradiated HMEC
is insufficient to drive the EMT phenotype. These data indicate that
irradiated cells undergo TGFß mediated EMT.9
To identify the genetic programs underlying EMT, we compared
transcript expression levels in sham, IR-, TGFß-, and double-treated
HMEC. We identified 10 genes that constituted the double treatment
signature. An extensive bibliography search showed that 5 of the
10 EMT signature genes are directly or indirectly associated with
the Erk/MAPK pathway, suggesting a specific functional role of
Erk/MAPK activation in inducing EMT upon double treatment.
Consequently, we examined the possible involvement of the Erk/
MAPK signaling cascade in the mediation of TGFß-induced EMT in
irradiated HMEC and found persistent activation of Erk/MAPK in
double-treated HMEC. Consistent with this, Erk phosphorylation was
transiently induced by irradiation and persisted in irradiated cells
treated with TGFß, and inhibition of Erk activation, blocked the EMT
phenotype. These findings identify a previously un-described path-
way in which interactions between radiation-induced signaling path-
ways elicit heritable phenotypes that could contribute to neoplastic
progression.
Preliminary data comparing eqi-toxic doses of 1Gy of 1 GeV/amu
56Fe vs 2Gy of 137Cs ã-radiation showed comparable EMT in monolayer
and disrupted 3D morphogenesis when cells were cultivated in the
presence of TGFß. However, radiation dose response studies show
that this effect has a very low threshold in that a single exposure
of 3-200 cGy ã-radiation elicits the 'same' phenotypic switch.
Discussion/Conclusions
We have shown that the progeny of irradiated HMEC are dramati-
cally sensitized to undergo TGFß-induced EMT. IR and TGFß coop-
erated to induce a phenotypic transition that occurred in the progeny
of cells irradiated once and persisted even in the absence of TGFß.
This resulted in increased motility, enhanced invasion, and disrupted
epithelial morphogenesis and was accompanied by a distinct pattern
of gene expression. Neither chronic TGFß signaling induced by irra-
diation nor supplementation with low TGFß concentrations was
sufficient to induce the EMT phenotype in any of the three HMEC
that were examined in our studies. EMT occurred only in irradiated
HMEC in the presence of TGFß. Expression profiling distinguished
between genes regulated by TGFß without concomitant EMT in non-
malignant HMEC and genes that are differentially expressed under
conditions resulting in EMT. These differentially expressed genes
suggested the involvement of Erk/MAPK signaling, which was further
supported by experimental studies showing that this is required for
establishing and maintaining EMT and is essential for the functional
response, i.e., enhanced migration. We propose a model in which IR-
induced Erk/MAPK signaling is sustained by TGFß is necessary for
EMT. Notably, EMT occurred in cells exposed to sparsely or densely
ionizing radiation at very low doses, as does Erk/MAPK signaling.11
These data are consistent with a non-targeted radiation effect.
Our current and earlier studies, have shown that irradiated nonma-
lignant HMEC undergo EMT only if they are exposed to additional
TGFß, as might be derived from the stroma in intact tissues.10 If
moderate radiation doses can prime pre-neoplastic cells to undergo
EMT in vivo, it could accelerate cancer progression. An interesting
implication from our study is that normal epithelia may undergo
EMT in response to irradiation and TGFß, which could contribute
to fibrosis following radiotherapy. If so, this would lend further
credence to the potential application of TGFß inhibitors in radio-
therapy.12,13 However, additional studies from our laboratory indicate
that TGFß is instrumental in mounting a DNA damage response and
in inducing apoptosis of genomically unstable cells.5,14,15 The com-
plexity of radiation effects mediated by TGFß will require further
study to determine whether it plays a proximal role in suppressing
or promoting radiogenic carcinogenesis.
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